People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Pharma, Mining & Resources
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Endogena Therapeutics, Inc. | — | Pharma | Series A | $15.3M | $124.6M | 2020 |
| Rock Tech Lithium Inc. | — | Mining & Resources | Seed | $3.5M | $797K | 2021 |
Dirk Harbecke at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dirk Harbecke on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Elona Baum | 1 | 5 |
| Aaron Weaver | 1 | 3 |
| Chris Wright | 1 | 2 |
| Peter Kausch | 1 | 2 |
| Simon Bodensteiner | 1 | 1 |
| Brad Barnett | 1 | 1 |
| Klaus Schmitz | 1 | 1 |
| Wolfgang Voigt | 1 | 1 |
| Markus Bertini | 1 | 1 |
| Daniel Zabrowski | 1 | 1 |
| Matthias Steger | 1 | 1 |
| Beate Degen | 1 | 1 |
| Kerstin Wedemann | 1 | 1 |
| Mirco Wojnarowicz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.